These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24292677)

  • 21. Human herpesvirus 8-encoded vGPCR activates nuclear factor of activated T cells and collaborates with human immunodeficiency virus type 1 Tat.
    Pati S; Foulke JS; Barabitskaya O; Kim J; Nair BC; Hone D; Smart J; Feldman RA; Reitz M
    J Virol; 2003 May; 77(10):5759-73. PubMed ID: 12719569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphatic reprogramming by Kaposi sarcoma herpes virus promotes the oncogenic activity of the virus-encoded G-protein-coupled receptor.
    Aguilar B; Choi I; Choi D; Chung HK; Lee S; Yoo J; Lee YS; Maeng YS; Lee HN; Park E; Kim KE; Kim NY; Baik JM; Jung JU; Koh CJ; Hong YK
    Cancer Res; 2012 Nov; 72(22):5833-42. PubMed ID: 22942256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular studies and therapeutic targeting of Kaposi's sarcoma herpesvirus (KSHV/HHV-8) oncogenesis.
    Mesri EA; Cavallin LE; Ashlock BM; Leung HJ; Ma Q; Goldschmidt-Clermont PJ
    Immunol Res; 2013 Dec; 57(1-3):159-65. PubMed ID: 24203444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.
    Cathomas G
    Herpes; 2003 Dec; 10(3):72-7. PubMed ID: 14759339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
    Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
    Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kaposi sarcoma-associated herpes virus (KSHV) G protein-coupled receptor (vGPCR) activates the ORF50 lytic switch promoter: a potential positive feedback loop for sustained ORF50 gene expression.
    Bottero V; Sharma-Walia N; Kerur N; Paul AG; Sadagopan S; Cannon M; Chandran B
    Virology; 2009 Sep; 392(1):34-51. PubMed ID: 19640558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells.
    Keller SA; Schattner EJ; Cesarman E
    Blood; 2000 Oct; 96(7):2537-42. PubMed ID: 11001908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype.
    Grossmann C; Podgrabinska S; Skobe M; Ganem D
    J Virol; 2006 Jul; 80(14):7179-85. PubMed ID: 16809323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic reprogramming of Kaposi's sarcoma associated herpes virus infected B-cells in hypoxia.
    Singh RK; Lang F; Pei Y; Jha HC; Robertson ES
    PLoS Pathog; 2018 May; 14(5):e1007062. PubMed ID: 29746587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat.
    Guo HG; Pati S; Sadowska M; Charurat M; Reitz M
    J Virol; 2004 Sep; 78(17):9336-42. PubMed ID: 15308728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease.
    Marcelin AG; Motol J; Guihot A; Caumes E; Viard JP; Dussaix E; Cadranel J; Frances C; Carcelain G; Calvez V; Dupin N
    J Infect Dis; 2007 Oct; 196(8):1163-6. PubMed ID: 17955434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).
    Chadburn A; Hyjek EM; Tam W; Liu Y; Rengifo T; Cesarman E; Knowles DM
    Histopathology; 2008 Nov; 53(5):513-24. PubMed ID: 18983461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
    Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J
    J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of CCL20 production by Kaposi sarcoma-associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-kappaB activation.
    Punj V; Matta H; Schamus S; Yang T; Chang Y; Chaudhary PM
    Blood; 2009 May; 113(22):5660-8. PubMed ID: 19324905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human herpesvirus 8 open reading frame 26 and open reading frame 65 sequences from multiple myeloma patients: a shared pattern not found in Kaposi's sarcoma or primary effusion lymphoma.
    Ma HJ; Sjak-Shie NN; Vescio RA; Kaminsky M; Mikail A; Pold M; Parker K; Beksac M; Belson D; Moss TJ; Wu CH; Zhou J; Zhang L; Chen G; Said JW; Berenson JR
    Clin Cancer Res; 2000 Nov; 6(11):4226-33. PubMed ID: 11106236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative analysis of Kaposi sarcoma-associated herpesvirus (KSHV) in KSHV-associated diseases.
    Asahi-Ozaki Y; Sato Y; Kanno T; Sata T; Katano H
    J Infect Dis; 2006 Mar; 193(6):773-82. PubMed ID: 16479510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus.
    Kedes DH; Lagunoff M; Renne R; Ganem D
    J Clin Invest; 1997 Nov; 100(10):2606-10. PubMed ID: 9366576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A major role for Nrf2 transcription factors in cell transformation by KSHV encoded oncogenes.
    Sapochnik D; Raimondi AR; Medina V; Naipauer J; Mesri EA; Coso O
    Front Oncol; 2022; 12():890825. PubMed ID: 36212441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focal adhesion kinase is required for KSHV vGPCR signaling.
    He M; Bakken T; Kassimova A; Boshoff C; Philpott N; Cannon ML
    Mol Carcinog; 2012 Apr; 51(4):339-51. PubMed ID: 21538577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.